CYCC Cyclacel Pharmaceuticals Inc

Cyclacel Pharmaceuticals Inc is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, mechanism-targeted drugs to treat cancer and other serious disorders, with development operations in US and UK.

$7.37
As of 03/02/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
03/28/2006
7,103,650
1,444,301
$52,353,901
0.00%
SEC Edgar Online
10-Q
10-K
23254L603
US23254L6039
BLR6795

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
9.16
0.00
-25.39%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy